Quick Links
Connect with Us
Need Help? Have a Question?
 

When are Data and Safety Monitoring Boards (DSMBs) needed?

NIH Guidance on When Data and Safety Monitoring Boards (DSMBs) are Needed

The NIH requires a data and safety monitoring board (DSMB) for Phase III clinical investigations (or any multi-site clinical trial) involving interventions that entail potential risk to participants. For phase I and II trials, a DSMB may be appropriate if the studies have multiple clinical sites, are blinded, or employ particularly high-risk interventions or vulnerable populations. The NCRR requires a DSMB for any investigation that places participants at significant risk.

Documents Available from NIH Agencies

SourceTitle
NIHFurther Guidance On Data And Safety Monitoring For Phase I And Phase II Investigations
(Notice: OD-00-038, June 5, 2000)
NIHPolicy For Data And Safety Monitoring
(Notice: OD-98-084, June 10, 1998)
NCIEssential Elements of a Data and Safety Monitoring Plan for Clinical Investigations Funded by the National Cancer Institute
NH LBIEstablishing Data and Safety Monitoring Boards (DSMBs) and Observational Study Monitoring Boards (OSMBs)
NH LBIResponsibilities of Data and Safety Monitoring Boards (DSMBs) Appointed by Participating Institutions
Contact Us / Ask the Research Navigator

Ask the Research Navigator

Request Services

Request Services

Please sign in below to access this form.

Access to this form is restricted to ITHS Members. Please sign in.

Not yet an ITHS member?
Members of ITHS are part of a unique catalyst that accelerates discoveries to practice. If you haven't signed up for an ITHS membership yet, learn more and join us.

Lost your password?

Cite ITHSThe Institute is supported by grants UL1 TR002319, KL2 TR002317, and TL1 TR002318 from the NIH National Center for Advancing Translational Sciences through the Clinical and Translational Science Awards Program (CTSA).

Please help us continue to support your research by citing our grant number(s) in publications we supported.